Evidence map›Paper›PMID 38522426›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Otoferlin gene therapy restores hearing in deaf children.

John V Brigande

Open access · bronzeAbstract readEditorial
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. UtilizingJournal of developmental biology · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

John V BrigandeOregon Hearing Research Center and Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA. Electronic address: brigande@ohsu.edu.
Oregon National Primate Research Center · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Fetal gene therapy for congenital deafness and imbalance (Administrative Supplement)R21DC018126 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRIGANDE, JOHN VINCENT, HENNEBOLD, JON D · 2019 to 2021
$651k
NIDCD NIH HHS R21 DC018126NIH HHS P51 OD011092
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DeafnessHearingChildGenetic TherapyHumans

Identifiers

PMID38522426
PMCPMC11163207
OpenAlexW4393111762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.